Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Public interest in finasteride's sexual side effects has significantly increased.

There is a significant need for better-validated quality of life tools in dermatology.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Hair loss in women linked to higher sexual dysfunction risk.

Finasteride is considered the best treatment for hair loss, despite side effects.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Men with lower education levels are more likely to have erectile dysfunction if they have coronary artery disease.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Finasteride does not negatively affect male reproductive function.

Ginseng may be beneficial for skin health and treating various skin conditions.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Finasteride helps female-pattern hair loss.